![Anju Software Anju Software](https://vertassets.blob.core.windows.net/image/b2f64174/b2f64174-0449-49bb-afa7-4d7d11dff938/anju_horizontal_logo_rgb_tagline1.jpg)
ABOUT ANJU SOFTWARE
Anju is a customer-first organization providing adaptable life science solutions for clinical research, medical affairs, and data science. TrialMaster, IRMS MAX, and TA Scan, the company’s flagship products, reduce complexities in the drug and device discovery and commercialization process allowing our customers to enhance the quality of their patients’ lives. Anju is a portfolio company of Abry Partners serving the worldwide pharmaceutical, biotech, and contract research life sciences markets.
FEATURED ARTICLES
-
Discover how integrating internal and external data can enhance decision-making and efficiency, how to manage diverse data sources, and the benefits of a single source of truth for your organization.
-
Navigating the intricacies of clinical trials demands adept handling of document management, regulatory compliance, and financial forecasting. Learn key strategies for overcoming these hurdles.
-
Life sciences companies are grappling with a deluge of data. Yet, strategic data management outsourcing offers potential benefits amidst regulatory and interoperability hurdles.
-
In an era emphasizing patient-centered care, the FDA's guidance on diversity, equity, and inclusion in clinical trials highlights a progressive shift. But what does a truly patient-centric trial involve?
-
Medical affairs are vital, bridging pharma, professionals, and patients. Explore insights for navigating industry shifts, leveraging technology, and empowering professionals in this dynamic landscape.
-
Clinical trial enrollment poses significant challenges for researchers. Leveraging pharmacies offers a solution due to their accessibility and established patient trust.
-
Explore the enduring principles of patient-centered care, the disconnect in clinical trial practices, and strategies needed to truly integrate a patient-centric approach from trial planning to execution.
-
Diversity in clinical trials is vital for advancing research and ensuring equitable care. Explore the significance of diversity, the DEPICT Act's role, and collaborative efforts to foster inclusivity.
-
Delve into strategies for effectively monitoring and reporting progress toward achieving patient diversity objectives.
-
Online medical misinformation abounds, and pharmaceutical companies need dedicated MA resources to communicate with HCPs and consumers to ensure the material they find is up-to-date and accurate.
-
Utilize this guidance as a valuable resource in navigating the evolving landscape of clinical research in innovative and transformative fields.
-
Uncover how advancements in clinical trial management systems signify a significant shift towards more streamlined and effective clinical trial management, ultimately enhancing the quality and pace of medical research endeavors.
-
Better understand how the DEPICT Act not only underscores the importance of diversity in research but also sets the stage for a more inclusive and comprehensive approach to healthcare development.
-
Discover how the integration of EDC technology benefits researchers and can hasten treatment and therapy development, improving the lives of patients.
-
In a recent webinar, members from Anju Software and St. Jude’s came together to discuss what makes oncology trials unique, how technology can assist with the humane aspects as well as the urgency of treatment, and how Anju helps their customers meet these challenges.
-
Drug development is slow and costly. Learn how a state-of-the-art system can increase efficiency and ROI by providing valuable data insights and superior customer service.
-
Oncology clinical trials can be very complex, as are their data management needs. Understand why selecting the right EDC is crucial for managing them efficiently while providing compassionate care.
-
Consider these steps when creating a more inclusive environment and how enrolling participants in clinical trials from underrepresented racial and ethnic populations can make cancer care more equitable.
-
Learn why it’s important to build strong relationships with opinion leaders in the healthcare industry, as well as how to establish and maintain them.
-
Explore the importance of historical data in clinical trials and the potential benefits it can provide for researchers and healthcare professionals.
CONTACT INFORMATION
Anju Software
4500 S Lakeshore Drive
Tempe, AZ 85282
UNITED STATES